EUVIMEDEUVIMED entdecken
Vergleichsstudie

Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care

Pooja Gokhale, Lorenzo Villa Zapata

The American Journal of Managed Care · 18.11.2025 · 31 (11) · e322

DOI: 10.37765/ajmc.2025.89822 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The American Journal of Managed Care, online erschienen am 18.11.2025. Verfasst von Pooja Gokhale und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Georgia College of Pharmacy, 250 W Green St, Athens, GA 30602. Email: lorenzo.villazapata@uga.edu. Hauptthemen laut MEDLINE: Migraine Disorders, Pyridines, Calcitonin Gene-Related Peptide Receptor Antagonists, Piperidines. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersPyridinesCalcitonin Gene-Related Peptide Receptor AntagonistsPiperidinesPyrrolesPyrazolesHumansCost-Benefit AnalysisMarkov ChainsQuality-Adjusted Life YearsUnited StatesAcute DiseaseCost-Effectiveness Analysis

Substanzen

PyridinesubrogepantCalcitonin Gene-Related Peptide Receptor AntagonistsPiperidinesrimegepant sulfatePyrrolesPyrazoles

Autor:innen und Institutionen

  • University of Georgia College of Pharmacy, 250 W Green St, Athens, GA 30602. Email: lorenzo.villazapata@uga.edu.

Zitieren

APA

Gokhale, P., & Villa Zapata, L. (2025). Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care. The American Journal of Managed Care, 31(11), e322. https://doi.org/10.37765/ajmc.2025.89822

Vancouver

Gokhale P, Villa Zapata L. Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care. The American Journal of Managed Care. 2025;31(11):e322. doi:10.37765/ajmc.2025.89822

BibTeX
@article{Gokhale2025,
  author = {Gokhale, Pooja and Villa Zapata, Lorenzo},
  title = {Cost-Effectiveness Analysis of Ubrogepant, Rimegepant, and Zavegepant for Acute Migraine Treatment vs Usual Care},
  journal = {The American Journal of Managed Care},
  year = {2025},
  volume = {31},
  number = {11},
  pages = {e322},
  doi = {10.37765/ajmc.2025.89822}
}
Kostenlos starten →